GAMMA SECRETASE MODULATORS
    22.
    发明申请
    GAMMA SECRETASE MODULATORS 审中-公开
    GAMMA秘密调节器

    公开(公告)号:US20100298372A1

    公开(公告)日:2010-11-25

    申请号:US12747001

    申请日:2008-12-09

    CPC分类号: C07D455/02

    摘要: This invention provides novel compounds that are modulators of gamma secretase. The compounds have the formula (I). Also disclosed are methods of modulating gamma secretase activity and methods of treating Alzheimer's disease using the compounds of formula (I).

    摘要翻译: 本发明提供了作为γ分泌酶调节剂的新型化合物。 化合物具有式(I)。 还公开了使用式(I)的化合物调节γ-分泌酶活性和治疗阿尔茨海默病的方法的方法。

    Gamma secretase modulators
    26.
    发明授权
    Gamma secretase modulators 有权
    伽玛分泌酶调节剂

    公开(公告)号:US08426595B2

    公开(公告)日:2013-04-23

    申请号:US12747011

    申请日:2008-12-09

    IPC分类号: C07D498/02 A61K31/44

    CPC分类号: C07D487/04 C07D471/04

    摘要: This invention provides novel compounds that are modulators of gamma secretase. The compounds have the formula [Chemical formula should be inserted here as it appears on abstract in electronic form.] Also disclosed are methods of modulating gamma secretase activity and methods of treating Alzheimer's disease using the compounds of formula (I).

    摘要翻译: 本发明提供了作为γ分泌酶调节剂的新型化合物。 化合物具有式[化学式应该插入在此,其以电子形式的摘要出现。]还公开了使用式(I)化合物调节γ-分泌酶活性的方法和治疗阿尔茨海默氏病的方法。

    BICYCLIC PYRANONE DERIVATIVES AND METHODS OF USE THEREOF
    29.
    发明申请
    BICYCLIC PYRANONE DERIVATIVES AND METHODS OF USE THEREOF 审中-公开
    双相PYRANONE衍生物及其使用方法

    公开(公告)号:US20110243940A1

    公开(公告)日:2011-10-06

    申请号:US13139890

    申请日:2009-12-15

    CPC分类号: C07D491/052

    摘要: The present invention relates to Bicyclic Pyranone Derivatives, their compositions and uses for treating or preventing a metabolic disorder, dyslipidemia, a cardiovascular disease, a neurological disorder, a hematological disease, cancer, inflammation, a respiratory disease, a gastroenterological disease, diabetes, a diabetic complication, obesity, an obesity-related disorder or non-alcoholic fatty liver disease. Formula (I). Y is —C— when an optional and additional bond is present and Y is —CH— when an optional and additional bond is not present; Z is —O—, —NH— or —N(alkyl)- when the optional and additional bond between Y and Z Is absent, and Z Is —N— when the optional and additional bond between Y and Z is present; R1 is H1 halo or —CN; R2 is alkyl, alkenyl or -(alkyleneVcydoalkyl; t is 0 or 1; R3 is O when the optional and additional bond between Y and R3 is present, and R3 is alkyl.haloalkyl.—C(0)0R5.-alkylene-O-alkyt or —O-alkyl when the optional and additional bond between Y and R3 is absent: R4 is H, alkyl or aryl, wherein an aryl group can be unsubstituted or optionally substituted.

    摘要翻译: 本发明涉及双环吡喃酮衍生物,其组合物和用于治疗或预防代谢紊乱,血脂异常,心血管疾病,神经障碍,血液病,癌症,炎症,呼吸系统疾病,胃肠病,糖尿病, 糖尿病并发症,肥胖症,肥胖相关障碍或非酒精性脂肪性肝病。 式(I)。 当不存在任选和另外的键时,当存在任选的附加键且Y是-CH-时,Y是-C-; 当Y和Z之间的任选和另外的键不存在时,Z是-O - , - NH-或-N(烷基),当存在Y和Z之间的任选的和另外的键时,Z是 - R1为H1卤素或-CN; R 2是烷基,烯基或 - (亚烷基二烷基; t是0或1;当存在Y和R 3之间的任选和另外的键时,R 3是O,R 3是烷基卤代烷基-C(O) - 烷基或-O-烷基,当Y和R3之间的任选和另外的键不存在时:R4是H,烷基或芳基,其中芳基可以是未取代的或任选被取代的。